Abstract:Drug-target affinity prediction is a challenging task in drug discovery. The latest computational models have limitations in mining edge information in molecule graphs, accessing to knowledge in pharmacophores, integrating multimodal data of the same biomolecule and realizing effective interactions between two different biomolecules. To solve these problems, we proposed a method called Graph features and Pharmacophores augmented Cross-attention Networks based Drug-Target binding Affinity prediction (GPCNDTA). First, we utilized the GNN module, the linear projection unit and self-attention layer to correspondingly extract features of drugs and proteins. Second, we devised intramolecular and intermolecular cross-attention to respectively fuse and interact features of drugs and proteins. Finally, the linear projection unit was applied to gain final features of drugs and proteins, and the Multi-Layer Perceptron was employed to predict drug-target binding affinity. Three major innovations of GPCNDTA are as follows: (i) developing the residual CensNet and the residual EW-GCN to correspondingly extract features of drug and protein graphs, (ii) regarding pharmacophores as a new type of priors to heighten drug-target affinity prediction performance, and (iii) devising intramolecular and intermolecular cross-attention, in which the intramolecular cross-attention realizes the effective fusion of different modal data related to the same biomolecule, and the intermolecular cross-attention fulfills the information interaction between two different biomolecules in attention space. The test results on five benchmark datasets imply that GPCNDTA achieves the best performance compared with state-of-the-art computational models. Besides, relying on ablation experiments, we proved effectiveness of GNN modules, pharmacophores and two cross-attention strategies in improving the prediction accuracy, stability and reliability of GPCNDA. In case studies, we applied GPCNDTA to predict binding affinities between 3C-like proteinase and 185 drugs, and observed that most binding affinities predicted by GPCNDTA are close to corresponding experimental measurements.

Predicting drug–target binding affinity with cross-scale graph contrastive learning

HSGCL-DTA: Hybrid-scale Graph Contrastive Learning Based Drug-Target Binding Affinity Prediction

GraphCL-DTA: a graph contrastive learning with molecular semantics for drug-target binding affinity prediction

Drug-target Binding Affinity Prediction Model Based on Multi-Scale Diffusion and Interactive Learning

Supervised graph co-contrastive learning for drug–target interaction prediction

Drug-target Affinity Prediction Method Based on Multi-Scale Information Interaction and Graph Optimization

Drug–target affinity prediction with extended graph learning-convolutional networks

Drug-Target Binding Affinity Prediction by Combination Graph Neural Network and BiLSTM

Drug Target Affinity Prediction Based on Graph Structural Enhancement and Multi-scale Topological Feature Fusion

AttentionMGT-DTA: A multi-modal drug-target affinity prediction using graph transformer and attention mechanism

Drug-Target Affinity Prediction Based on Improved GraphDTA

Drug-target interaction prediction with collaborative contrastive learning and adaptive self-paced sampling strategy

GPCNDTA: Prediction of drug-target binding affinity through cross-attention networks augmented with graph features and pharmacophores

SSR-DTA: Substructure-aware multi-layer graph neural networks for drug-target binding affinity prediction

Multidta: drug-target binding affinity prediction via representation learning and graph convolutional neural networks

A deep learning method for drug-target affinity prediction based on sequence interaction information mining

Hierarchical graph representation learning for the prediction of drug-target binding affinity

Prediction of drug-target binding affinity based on multi-scale feature fusion

Predicting Drug-Target Affinity Using Protein Pocket and Graph Convolution Network

Contrastive Meta-Learning for Drug-Target Binding Affinity Prediction

Drug–target Affinity Prediction Using Graph Neural Network and Contact Maps